Duplication 6q24: More Than Just Diabetes
- PMID: 32373772
- PMCID: PMC7185952
- DOI: 10.1210/jendso/bvaa027
Duplication 6q24: More Than Just Diabetes
Abstract
Chromosome 6q24-related transient neonatal diabetes mellitus is characterized by intrauterine growth restriction and low birth weight, with neonatal hyperglycemia resolving by 18 months and an increased risk for type 2 diabetes in adulthood. Molecularly, it is caused by overexpression of the 6q24 imprinted chromosomal region due to a duplication, uniparental disomy, or abnormal methylation. Conventional testing for this condition analyzes methylation patterns at the 6q24 locus but does not evaluate for the presence of other surrounding chromosomal abnormalities. We report a female with a history of neonatal hyperglycemia due to a paternally inherited duplication at chromosomal location 6q24. She subsequently presented to the pediatric genetics clinic at 15 months of age with developmental delay and abnormal balance. Microarray analysis identified a larger 14 Mb chromosomal duplication from 6q24 to 6q25.2, consistent with a diagnosis of duplication 6q syndrome. This case highlights the clinical importance of pursuing further genetic evaluation in patients diagnosed with chromosome 6q24-related neonatal hyperglycemia via targeted methylation-specific multiplex ligation-dependent probe amplification analysis identifying a duplication in this region. Early identification and intervention can improve developmental outcomes for patients with larger chromosome 6q duplications.
Keywords: chromosome abnormality; duplication 6q24; genetic testing; transient neonatal diabetes.
Published by Oxford University Press on behalf of the Endocrine Society 2020.
References
-
- Docherty LE, Kabwama S, Lehmann A, et al. . 6q24 transient neonatal diabetes mellitus (6q24 TNDM) – clinical presentation and genotype phenotype correlation in an international cohort of cases. Diabetologia. 2013;56:758–762. - PubMed
-
- Pearson ER, Flechtner I, Njølstad PR, et al. ; Neonatal Diabetes International Collaborative Group Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med. 2006;355(5):467–477. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous